Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I

Non-small cell lung cancer (NSCLC) comprises of 84% of all lung cancer cases. The treatment options for NSCLC at advanced stages are chemotherapy and radiotherapy. Chemotherapy involves conventional nonspecific chemotherapeutics, and targeted-protein/receptor-specific small molecule inhibitors. Biol...

Celý popis

Podrobná bibliografia

Vydané v:	Expert opinion on drug delivery Ročník 18; číslo 1; s. 73 - 102
Hlavní autori:	Upadhya, Archana, Yadav, Khushwant S., Misra, Ambikanandan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Taylor & Francis 02.01.2021
Predmet:	immunotherapy Non-small cell lung cancer resistance targeted therapy therapeutics in clinics targeted therapy therapeutics in clinics resistance Non-small cell lung cancer immunotherapy
ISSN:	1742-5247, 1744-7593, 1744-7593
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!